ELDERPHARM

Dr. Anuj Saxena has submitted to the Exchange vide letter dated April 02, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings pvt ltd has submitted to the Exchange vide letter dated April 03, 2014 a copy of Disclosure in terms of Regulation 29(1), 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Alok J Saxena has submitted to the Exchange vide letter dated April 02, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings pvt ltd has submitted to the Exchange vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports pvt ltd has submitted to the Exchange vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide letter dated April 02, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated April 02, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Instruments Pvt Ltd has submitted to the Exchange, vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Projects Ltd has submitted to the Exchange vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange, vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Projects Limited has submitted to the Exchange, vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange, vide letter dated April 01, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder health Care Limited has submitted to the Exchange vide letter dated March 28, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated March 21, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Projects Limited has submitted to the Exchange vide letter dated March 21, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Private Ltd has submitted to the Exchange vide letter dated March 21, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Exchange had sought clarification from Elder Pharmaceuticals Limited with respect to a news item captioned "Elder Pharma in revamp mode". The Company has clarified that "the Company has informed the Exchange on December 13,2013 about the sale of its formulation business in India and Nepal to Torrent Pharmaceuticals Limited. Post this deal, the Company's overall strategy is to focus on its remaining brands inclusive Eldervit and Somazina and position itself further in the growing neutraceuticals segment by launching more products of its own. Also the Company is also planning to concentrate

Elder Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Dec-2013.

Elder Pharmaceuticals Limited has informed the Exchange regarding a voting result of the Postal Ballot held on February 10, 2014 under Clause 35A of the Listing Agreement.

Indarts Exports Pvt ltd has submitted to the Exchange vide letter dated February 03, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

DCB Bank Limited has submitted to the Exchange vide letter dated January 16, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Projects Limited has submitted to the Exchange vide letter dated January 14, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sneh J Saxena has submitted to the Exchange vide letter dated January 06, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide letter dated January 08, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Alok J Saxena has submitted to the Exchange, vide letter dated January 07, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide letter dated January 07, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated january 07, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has submitted to the Exchange a copy of notice of postal ballot pursuant to Section 180(1)(a) of the companies Act, 2013 read with Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide letter dated December 31, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange regarding a Outcome of Annual General Meeting of the Company held on December 30, 2013.

Akshaya Holdings Pvt ltd has submitted to the Exchange vide letter dated December 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Elder Pharmaceuticals Limited has informed the Exchange that the Company has fixed Book Closure from December 23, 2013 to December 30, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on December 30, 2013.

Elder Pharmaceuticals Limited has informed the Exchange that a meeting of the empowered Committee of the Board of the Company was held on December 13, 2013 and the said Committee has approved the definitive agreement and entered into Business Transfer Agreement (BTA) for the sale of domestic formulation business to Torrent Pharmaceuticals Ltd. Further the Company has submitted a copy of the press release dated December 13, 2013, titled, "Torrent to Acquire Indian Branded Formulations Business of Elder".

Elder Pharmaceuticals Limited has informed the Exchange vide letter dated November 22, 2013 regarding Clarification / Confirmation on news item spearing in the newapaper.

Elder Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-sep-2013.

Elder Pharmaceuticals Limited has given clarification to the Exchange regarding the news item that appeared on November 01, 2013. "This refers to the news item that appeared in the Economic Times, Mumbai Edition on Friday the 1st November 2013. It was reported with the headline Elder Pharma Defaults on Rs. 261 cr Interest Payment on Debentures. While the Company has defaulted in interest payment on Debentures the fact is that the default is only to the tune of Rs. 10 crores and not Rs. 261 crores as reported. The error in reporting was corrected by Economic Times, Mumbai Edition on Thursday t

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 11, 2013, has decided to appoint Mr. Alok Saxena as the Managing Director and Chief Executive Officer of the Company with effect from October 11, 2013, for a period of five years, subject to the approval of the shareholders.

Elder Pharmaceuticals Limited has informed the Exchange that Mr. Jagdish Saxena, the Chairman and Managing Director of the Company, passed away on October 10, 2013 after a prolonged illness.

Elder Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended June 30,2013.

Elder Pharmaceuticals Limited has informed the Exchange that at a meeting of the Board of Directors of the Company held on July 11, 2013, the Board with a view to reducing the debt of the Company has approved the proposal for carrying out restructuring of Company's business involving either raising of capital, hiving off of assets or other strategic options and have decided to appoint advisors for this purpose.

Elder Pharmaceuticals Limited has submitted to the Exchange, vide letter dated June 03, 2013 a copy of disclosure pursuant to Regulation 13 of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Elder Pharmaceuticals Limited has informed the Exchange that NutraHealth Ltd. (a wholly owned step down subsidiary of Elder Pharmaceuticals Ltd. of Mumbai, India), the UK's leading provider of the highest quality and innovative branded and own label vitamin and food supplements, has acquired Max Healthcare Ltd. to re-enter the OTC pharmaceutical category and extend and enhance its product range. Max Healthcare is an OTC business which owns a range of marketing authorisations and provides own label and branded OTC medicines and products to a broad range of customers. Max Healthcare will be a su

News Verification : The media had reports that Elder Pharmaceuticals Limited is in process to sell its domestic formulation business.. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "As informed earlier, at this stage the company does not have any definite proposal for sale of its domestic formulations business. The Company has been looking for opportunities of o

News Verification : The media had reports that the Promoters are in the process to sell stake in Elder Pharmaceuticals Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated,"As far as the Company is aware, there is no proposal of the promoters to sell the shares in the Company. The Company is constantly looking to add value to the shareholders and keeps conside

Indarts Exports Private Limited has submitted to the Exchange vide letter dated May 23, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on May 14, 2013 has decided not to proceed with amalgamation of Elder Health Care Ltd., with the Company.

Elder Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.

Elder Pharmaceuticals Limited has informed the Exchange that : "Ratnakar Bank Ltd. have invoked pledge of our Company's shares and have on 10th and 11th instants sold some of them in the market. This has affected the market price of the shares and the volume also has increased. However, kindly note that neither the promoters nor persons acting in concert have sold any shares in the market".

Elder Pharmaceuticals Limited has informed the Exchange that: "On 10th and 11th instants Ratnakar Bank Ltd. have sold shares of our Company in the market because of which the market price of the shares has come down and volume also has increased. However, kindly note that neither the promoters nor persons acting in concert have sold any shares in the market".